Hafnia alvei endocarditis following pyelonephritis in a permanent pacemaker carrier

Clin Infect Dis. 2007 Feb 15;44(4):621. doi: 10.1086/511084.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Comment

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Carrier State / microbiology
  • Device Removal
  • Echocardiography, Transesophageal
  • Endocarditis, Bacterial / diagnostic imaging
  • Endocarditis, Bacterial / drug therapy
  • Endocarditis, Bacterial / etiology*
  • Enterobacteriaceae Infections / diagnosis*
  • Enterobacteriaceae Infections / drug therapy
  • Follow-Up Studies
  • Hafnia alvei / isolation & purification*
  • Humans
  • Male
  • Pacemaker, Artificial / adverse effects
  • Pacemaker, Artificial / microbiology*
  • Pyelonephritis / drug therapy
  • Pyelonephritis / etiology
  • Pyelonephritis / microbiology*
  • Recurrence
  • Risk Assessment
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents